Saxenda Saxenda is another GLP-1 medication approved by the FDA for weight management in adults with obesity and adults with overweight and weight-related medical concerns
If generalised itching occurs with jaundice, dark urine or pale stools, urgent medical review is needed to investigate possible hepatobiliary disease
Semaglutide can reduce hunger, but it does not automatically fix poor nutrition quality, low activity, alcohol excess, chronic stress, or hormonal issues that may be contributing to weight gain
Warning about freezing: Never freeze the pens or cartridges
It is important to recognise that patients prescribed GLP-1 agonists often have underlying conditionssuch as type 2 diabetes, obesity, hypertension, and dyslipidaemiathat independently increase cardiovascular and thrombotic risk